News Center

News Center

Dr. Tong Wang, Chief Scientific Officer of Shengshi Taikang, has been selected as a "Double Innovation Talent" in Jiangsu Province.

Dr. Tong Wang, Chief Scientific Officer of Shengshi Taikang, has been selected as a "Double Innovation Talent" in Jiangsu Province.

Recently, Dr. Wang Tong, Chief Scientific Officer of Shengshi Taikang, was selected for the "2023 Jiangsu Province High-Level Innovation and Entrepreneurship Talent Introduction Program," as announced during the awarding ceremony of the "Double Innovation Talent Plan" organized by the Jiangsu Provincial People's Government and the Provincial Committee Talent Office. Led by Dr. Wang, Shengshi Taikang's R&D team is dedicated to developing high-quality, differentiated small-molecule innovative drugs aimed at addressing critical unmet clinical needs in areas such as blood sugar control, cancer treatment, and autoimmune diseases.

Time：2024-07-31 17:45

Brainstorming | Setting Sail Through Metabolism, Exploring the Stars and the Sea

Brainstorming | Setting Sail Through Metabolism, Exploring the Stars and the Sea

With the advancement of the "Healthy China 2030 Planning Outline," chronic disease medications have become a key focus in pharmaceutical R&D. Among these, the development of cardiovascular, lipid-lowering, and blood sugar- and weight-management drugs has particularly emerged as a hot trend in the industry. Recently, ResearcherTalk and Haomai Technology co-hosted a "brainstorming session" in Zhuhai, centering on clinical needs, industry trends, and the latest advancements in metabolic disease drug development. Dr. Yu Qiang, Founder and CEO of Shengshitaike Innovation, attended the event and joined guests in exploring the vast potential of chronic disease therapies—from a metabolic perspective—toward groundbreaking innovations.

Time：2024-05-28 17:18

Shengshi Taikang once again ranks among the "Top 50 Most Influential Companies in China's Healthcare Sector."

Shengshi Taikang once again ranks among the "Top 50 Most Influential Companies in China's Healthcare Sector."

Recently, CHC Medical Consulting, in collaboration with CITIC Securities, officially unveiled the "2023 China Healthcare and Greater Health Industry Investment & Financing Honor List." As an innovative pharmaceutical company already in the commercialization phase, Shengshi Taikang once again made it onto this prestigious list, earning a spot among the Top 50 Most Influential Companies in China's Healthcare Sector for 2023.

Time：2024-05-17 17:09

Dr. Yu Qiang: Facing Industry Changes, Embracing the AI Future

Dr. Yu Qiang: Facing Industry Changes, Embracing the AI Future

Recently, the 9th EBC BIOCHINA (EBC) Yimao Bio-Industry Conference was held at the Suzhou International Expo Center. Dr. Yu Qiang, Founder and CEO of Shengshi Taike Innovation and Secretary-General of the Xinyao Club, attended the event and organized the "Small-Molecule Innovative Drug Development Forum." The forum特邀 over ten distinguished industry leaders to jointly discuss cutting-edge technologies and emerging targets in small-molecule drug development, exploring together with attendees how these molecules can continue to play a vital role in advancing future pharmaceutical research—and ultimately better address clinical needs.

Time：2024-03-22 17:04

Jiangsu Province Laboratory Animal License Annual Inspection Report

Jiangsu Province Laboratory Animal License Annual Inspection Report

Time：2024-02-05 23:23

World Diabetes Day | Empowering Diabetes Patients Through Innovation at the Source

World Diabetes Day | Empowering Diabetes Patients Through Innovation at the Source

Time：2023-11-16 14:40

Shengshi Taikang Information Disclosure on Prevention and Control of Environmental Pollution Caused by Hazardous Waste

Shengshi Taikang Information Disclosure on Prevention and Control of Environmental Pollution Caused by Hazardous Waste

Time：2023-08-19 11:47

Shengshi Taikang Honored as a "Pioneer Enterprise for Independent Innovation in China's Pharmaceutical Industry"

Shengshi Taikang Honored as a "Pioneer Enterprise for Independent Innovation in China's Pharmaceutical Industry"

Shengshi Taikang has been honored as a "Pioneer Enterprise for Independent Innovation in China's Pharmaceutical Industry."

Time：2023-08-16 17:42

< 1234...10 >
中企跨境-全域组件 制作前进入CSS配置样式

在线客服添加返回顶部

页面顺滑的滚动

屏蔽页面上图片的alt/title提示

右侧在线客服样式 1,2,3 2

图片alt标题设置： Fland Environmental

表单验证提示文本： The content cannot be empty!

循环体没有内容时： Content is being organized—please wait!

CSS / JS 文件放置地